Close Menu

meningitis

BioMérieux's BioFire Diagnostics subsidary and Cepheid sponsored presentations at the American Association for Molecular Pathology annual meeting in which clinical users shared preliminary data on highly anticipated products from the companies.

NEW YORK (GenomeWeb) — BioFire Diagnostics, a subsidiary of BioMérieux, said today that it has begun clinical and analytical studies to evaluate its FilmArray Meningitis/Encephalitis Panel with plans to seek both US Food and Drug Administration clearance and CE IVD marking.

Having recently been awarded a key US patent, Irish molecular diagnostics shop HiberGene hopes to commercialize its first assay — a loop-mediated isothermal amplification-based test for meningococcal meningitis — in Europe by the end of this year, CEO Tony Hill told PCR Insid

Ireland's HiberGene Diagnostics said this week that it has begun manufacturing its molecular diagnostic test for meningococcal meningitis

Australian molecular diagnostics and research tools firm SpeeDx has published research demonstrating how its proprietary class of nucleic acid enzymes, called MNAzymes, can be used in combination with standard qPCR reagents to enable easy, inexpensive development of highly sensit

A Wellcome Trust Sanger Institute-led team has sequenced and analyzed the genomes of more than 200 isolates from a drug-resistant Streptococcus pneumoniae lineage that emerged in Spain four decades ago.

Using the genome-wide association approach, researchers with the International Meningococcal Genetics Consortium have identified susceptibility variants for meningococcal disease in genes coding for components of the complement immune system.

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.